Vantage Vector (Demo)

Gaithersburg, MD
AAV Lentiviral
Program data pending ClinicalTrials.gov matching
59.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Vantage Vector (Demo)

Signal Score
59.0/100
Quality Compliance
Assessment pending
Headquarters
Gaithersburg, MD
Modalities
AAV, Lentiviral
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability 60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity 58.0
1 manufacturing site: Gaithersburg, MD
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100
Sites: Gaithersburg, MD
Source: SEC EDGAR, press monitoring, company profiles
1 manufacturing site
StatusAvailable
1 manufacturing site: Gaithersburg, MD
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100
Sites: Gaithersburg, MD
1 manufacturing site: Gaithersburg, MD
Modalities: AAV, Lentiviral
Capacity assessment: 58.0/100

Frequently Asked Questions About Vantage Vector (Demo)

What is Vantage Vector (Demo)'s CDMO Signal Score?
Vantage Vector (Demo) has a Signal Score of 59/100, based on quality, operations, financial stability, and capacity data.
Evaluating Vantage Vector (Demo) for a manufacturing program?
Use the free AI matchmaker to compare Vantage Vector (Demo) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
AAV CDMOs → Lentiviral CDMOs →

Similar CDMOs

Charles River Laboratories
Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score: 91.7
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
BioReliance (Merck)
Glasgow, UK · Rockville, MD
Signal Score: 81.0
AAV, Lentiviral, Biologics
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
Rose BioSolutions
Rockville, MD
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials
ReciBioPharm
Keele, UK · Sodertalje, SE
Signal Score: 88.0
AAV, Lentiviral, Plasmid, mRNA